Showing results (341-350 of 378) with videos related to
Sort By:
Pageof 38
Diabetes Care|June 18, 1999
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidantsS Mäkimattila, M L Liu, J Vakkilainen, et al.Circulation|April 6, 1999
Coronary flow reserve in young men with familial combined hyperlipidemiaO P Pitkänen, P Nuutila, O T Raitakari, et al.Atherosclerosis|March 21, 1997
Serum complement and familial combined hyperlipidemiaK Ylitalo, K V Porkka, S Meri, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|January 1, 1992
Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery diseaseM S Nieminen, K J Mattila, K Aalto-Setälä, et al.The American Journal of Clinical Nutrition|November 4, 2000
Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers StudyS C Couch, C R Isasi, W Karmally, et al.The Journal of Clinical Investigation|April 1, 1994
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic miceN S Shachter, T Hayek, T Leff, et al.Diabetologia|October 10, 2009
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetesN Tolonen, C Forsblom, L Thorn, et al.Journal of Internal Medicine|February 20, 2019
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kineticsE Björnson, C J Packard, M Adiels, et al.Clinical Therapeutics|January 1, 1989
Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US studyA C Goldberg, G Schonfeld, E B Feldman, et al.Pediatrics|September 5, 2001
Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers StudyP J Talmud, L Berglund, E M Hawe, et al.Pageof 38